Investigating how genital bacteria influence HIV risk
How sex, host microenvironment, and immune responses shape acquisition of genital bacteria that increase HIV risk
This study is looking at how certain bacteria in the genital area might influence the risk of getting HIV, with the hope of finding new ways to help prevent the virus, so people can better understand how their own bacteria might affect their HIV risk.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | George Washington University NIH-funded |
| Lab location | 1 site (Washington, United States) |
| Project ID | NIH-10993139 on NIH RePORTER |
What this research studies
This research explores the relationship between certain genital bacteria and the risk of acquiring HIV, particularly focusing on how these bacteria can affect immune responses. By studying the factors that contribute to the presence and persistence of these bacteria in the genital microbiome, the research aims to uncover new insights into HIV transmission dynamics. The project will involve analyzing both biological and environmental factors that influence the genital microbiome, with the goal of developing innovative prevention strategies against HIV. Patients may benefit from a better understanding of how their microbiome affects their HIV risk.
Who could benefit from this research
Good fit: Ideal candidates for this research include sexually active individuals, particularly men, who may be at risk for HIV due to the presence of certain genital bacteria.
Not a fit: Patients who are not sexually active or those who do not have any risk factors for HIV may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for preventing HIV transmission by targeting specific genital bacteria.
How similar studies have performed: Other research has indicated that understanding the microbiome can influence HIV transmission, suggesting that this approach has potential for success.
Where this research is happening
Washington, United States
- George Washington University — Washington, United States (Active)
Researchers
- Principal investigator: Liu, Cindy — George Washington University
- Study coordinator: Liu, Cindy
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.